"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
TO ARTICLE
METRICS

Case report
peer-reviewed

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia


Total Article Reads

Article reads consist of online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Total Article Reads Cureus PMC
2,654
Article Views 779 1,076
PDF Downloads 504 295
Total Article Reads Cureus PMC
2,654
Article Views 779 1,076
PDF Downloads 504 295
Total Article Reads
2,654
Cureus PMC
Article Views 779 1,076
PDF Downloads 504 295

Article Reads by Date

Hover your cursor over a specific day or month to see the corresponding online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Cureus Article Reads

Loading...

Cumulative Cureus and PMC Article Reads

Loading...

Article Reads by Country

Hover your cursor over a country to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank Country Views Percentage

Article Reads by U.S. States

Hover your cursor over a state to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank State Views Percentage

Citations

Citation index reporting varies. Crossref citations are listed below and Google Scholar citations can be seen by clicking the corresponding button.

Google Scholar  
Crossref Citations (6)
  1. Diamantopoulos, P. T., & Viniou, N.-A. (2021). Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.722507 doi:10.3389/fonc.2021.722507.
  2. Fontana, D., Gambacorti-Passerini, C., & Piazza, R. (2021). Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia. Frontiers in Oncology, 11. doi:10.3389/fonc.2021.756348.
  3. Castellino, A., Santambrogio, E., Rapezzi, D., & Massaia, M. (2021). Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment. Medicina, 57(10), 1104. doi:10.3390/medicina57101104.
  4. Takács, T., Kudlik, G., Kurilla, A., Szeder, B., Buday, L., & Vas, V. (2020). The effects of mutant Ras proteins on the cell signalome. Cancer and Metastasis Reviews. doi:10.1007/s10555-020-09912-8.
  5. Crisà, E., Nicolosi, M., Ferri, V., Favini, C., Gaidano, G., & Patriarca, A. (2020). Atypical Chronic Myeloid Leukemia: Where Are We Now? International Journal of Molecular Sciences, 21(18), 6862. doi:10.3390/ijms21186862.
  6. Levinson, K. B., & Bagg, A. (2017). Atypical Chronic Myeloid Leukemia, BCR/ABL1 Negative. Precision Molecular Pathology of Myeloid Neoplasms, 213–232. doi:10.1007/978-3-319-62146-3_11.

Article Research Metrics

We’ve partnered with Plum Analytics to track and display research metrics for each article. (All data provided by PlumX Metrics.) Click here to learn more about Plum Analytics.